• Contact Email
  • Phone Number 617-401-4060

Ra Pharma is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma is leveraging its ability to rapidly generate drug candidates to develop its own portfolio of products and partnerships focused on intracellular protein-protein interactions and other innovative approaches to addressing unmet medical needs.

It was founded in 2008 and headquartered in Cambridge, Massachusetts.

Read More

Lists Featuring This Company

Acquired East Coast Companies (Top 10K)
9,907 Number of Organizations • $148.8B Total Funding Amount • 14,004 Number of Investors
Northeastern US Pharmaceutical Companies
1,358 Number of Organizations • $41.9B Total Funding Amount • 2,227 Number of Investors
Greater Boston Area Biotechnology Companies
1,202 Number of Organizations • $52.7B Total Funding Amount • 3,479 Number of Investors
Northeastern US Companies (Top 10K)
9,979 Number of Organizations • $430.1B Total Funding Amount • 37,857 Number of Investors

M&A Details

Ra Pharmaceuticals was acquired by UCB Pharma for $2.1B on Oct 10, 2019.